Displaying 69 Zürich Biotech companies
 Filter
City
Country
Stage
Business Model
Industry
Clear All
Export
Zürich Switzerland Biotech All business models
company score funding investors employees industries biz model city contact
Cradle

Generative AI platform for protein design and engineering.
42
$24M · Series A Index Ventures, Kindred Capital 11 to 50 AI, Biotech B2B Zürich, Switzerland •••••••••••@cradle.bio
Anjarium Biosciences

Gene therapy research to tackle genetic diseases.
37
$59M · Series A Gimv 1 to 10 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@anjarium.com
TOLREMO therapeutics

Developer of small molecules to treat novel drug resistance pathways in cancer therapy.
37
$20M · Series A BioMedPartners, Altos Ventures, Redalpine 1 to 10 Health Tech, Biotech Zürich, Switzerland •••••••••••@tolremo.com
Memo Therapeutics

Antibody discovery and human immune repertoire analysis platform.
37
$27M · Series C Vesalius Biocapital Partners, Pureos Bioventures, Swisscanto Private Equity 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@memo-therapeutics.com
LimmaTech Biologics

Self-adjuvanting and multi-antigen vaccine technology platform.
31
$3M · Series A Novo A/S, AXA Investment Managers, Adjuvant Capital 11 to 50 Health Tech, Biotech Zürich, Switzerland •••••••••••@lmtbio.com
GlycoEra

Glycanengineering platform.
31
$49M · Series A Sofinnova Partners 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@glycoera.com
Microcaps

Microcaps develops a novel technology that enables the scalable production of precise microcapsules and microparticles.
26
$5M · Seed Helvetica Capital 1 to 10 Health Tech, Biotech, Manufacturing B2B Zürich, Switzerland •••••••••••@microcaps.ch
Invasight

Invasight is a clinical biotech company that focused on revolutionizing cell invasion research.
21
$4M · Seed High-Tech Gründerfonds, Verve Ventures 1 to 10 Health Tech, Biotech, Deep Tech B2B Zürich, Switzerland •••••••••••@invasight.com
Rejuveron Life Sciences

Rejuveron Life Sciences is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies.
20
$25M · Series A 1 to 10 Health Tech, Fintech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@rejuveron.com
BC Platforms

BC Platforms is a data and technology company providing tools to advance the development of personalized medicine and precision medicine.
20
$20M 51 to 100 Health Tech, Biotech, Deep Tech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Zürich, Switzerland •••••••••••@bcplatforms.com
Groam

Groam provide bio-based and biodegradable foam solutions for fast disposables.
17
$161k · Pre Seed Venture Kick Agritech, Biotech, Energy & Nuclear, Manufacturing B2B Zürich, Switzerland •••••••••••@groamtech.com
ImmunOs Therapeutics

Immunotherapy platform for cancer.
17
$330k · Pre Seed Lightspeed Venture Partners, BioMedPartners, Gimv 11 to 50 Health Tech, Biotech, Pharma B2B Zürich, Switzerland •••••••••••@immunostherapeutics.com
rqmicro

Rqmicro develops a pathogen separation and detection technology that delivers accurate results in less than 2 hours
17
$6M · Series B 11 to 50 Climate Tech & Green Tech, Health Tech, Biotech, Deep Tech, Energy & Nuclear, Business Intelligence B2B Zürich, Switzerland •••••••••••@rqmicro.com
Virometix

Virometix is a privately held biotechnology company developing
17
$8M · Series B 11 to 50 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@virometix.com
Navignostics

Navignostics aims to identify the ideal treatment to each cancer patient’s disease.
17
$7M 1 to 10 Health Tech, Hardware, Biotech, Deep Tech, Pharma Zürich, Switzerland •••••••••••@navignostics.com
Nanoflex Robotics

Medical robotics company.
17
$12M · Series A 11 to 50 Biotech Zürich, Switzerland •••••••••••@nanoflexrobotics.com
Araris Biotech

Developer of an antibody-drug conjugates (ADCs).
17
$110k · Pre Seed btov Partners, Pureos Bioventures, Redalpine 1 to 10 Health Tech, Biotech B2B Zürich, Switzerland •••••••••••@ararisbiotech.com
Medyria

Guided medical devices cardiovascular procedures.
14
$4M · Series B 1 to 10 Biotech Zürich, Switzerland •••••••••••@medyria.com
Vatorex

Vatorex enhances honey bee health through an effective and practicable hyperthermic system to fight the varroa mite.
10
$1M 1 to 10 Climate Tech & Green Tech, Agritech, Hardware, Biotech B2B Zürich, Switzerland •••••••••••@vatorex.ch
Biosimo

Biosimo Chemicals produces sustainable chemicals
10
$308k · Pre Seed 1 to 10 Biotech, Deep Tech, Proptech & Real Estate, Manufacturing B2B Zürich, Switzerland •••••••••••@biosimo-chemicals.com
PharmaBiome

PharmaBiome is specialized in the isolation, characterization, and technology of novel intestinal microbes.
4
N/A 1 to 10 Health Tech, Biotech, Deep Tech Zürich, Switzerland •••••••••••@pharmabiome.com
Molecular Partners

Molecular Partners is a clinical-stage biopharmaceutical company.
4
N/A 51 to 100 Biotech, Deep Tech Zürich, Switzerland •••••••••••@molecularpartners.com
Relief Therapeutics

Relief Therapeutics is a clinical stage biotechnology company.
4
N/A 11 to 50 Biotech, Deep Tech Zürich, Switzerland •••••••••••@relieftherapeutics.com